Insomnia: What to Know About Integrative Chiropractic Care

Find effective strategies for integrative chiropractic care for insomnia to help you achieve better sleep and wellness.

Abstract

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this comprehensive educational post, I guide you through an easy-to-understand journey into the world of insomnia: why it happens, how it affects the brain and body, and what truly works to restore healthy sleep. Drawing on the latest findings from leading researchers and my clinical experience in integrative care, I explain the neurophysiology of sleep, including the roles of circadian rhythm, sleep-wake homeostasis, adenosine, melatonin, histamine, and orexin; the architecture of non-REM and REM sleep; the glymphatic system’s nighttime waste clearance; and sleep’s impact on neuroplasticity, cognition, mood, metabolism, and disease risk.

I present modern, evidence-based strategies such as Cognitive Behavioral Therapy for Insomnia (CBT-I), sleep hygiene, stimulus control, sleep restriction, and pharmacologic options (e.g., dual orexin receptor antagonists, low-dose doxepin, melatonin agonists), explaining why and when to use each. I also show how integrative chiropractic care fits into a multidisciplinary model that addresses pain, autonomic regulation, and functional imbalances contributing to insomnia.

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, I collaborate with our Medical Director, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), who brings over 40 years of clinical experience to provide medical oversight and co-management. Together, we integrate chiropractic care, internal medicine, functional medicine, rehabilitation, and personal injury services—aligning research-driven methods with personalized treatment to help you reclaim restorative sleep and overall health.

Our Multidisciplinary, Integrative Care Model in El Paso, Texas

I practice at Injury Medical Clinic PA—also known as Mission Plaza Injury Medical Clinic—in El Paso, Texas. My credentials (DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST) enable me to assess health structurally, neurologically, metabolically, and functionally. Our model is collaborative at its core.

• Medical Director and Collaborative Physician: Dr. Maria Guadalupe Cardenas, MD

• • Board Certified in Internal Medicine
  • NPI #1164426749
  • Texas MD License #J2933
  • Over 40 years of experience as an internist
  • Provides medical oversight to ensure safety, diagnostic accuracy, and evidence-based treatment alignment

• Integrated Services We Provide

• • Integrative chiropractic care (structural alignment, neuromuscular optimization, autonomic balance)
  • Internal medicine evaluation and management (medical conditions, medication oversight, specialty referrals)
  • Functional medicine (root-cause analysis: hormonal, nutritional, inflammatory, gut-related, and metabolic drivers)
  • Personal injury care (acute and post-acute strategies for pain and sleep restoration)
  • Physical rehabilitation (movement retraining, pain modulation, and sleep-supportive exercise planning)
  • Nutritional counseling (metabolic support, circadian-friendly nutrition timing)

This multidisciplinary setup—an MD providing medical direction alongside a chiropractor—reflects best-practice standards in integrative and injury care clinics. It allows us to co-manage complex conditions like chronic insomnia safely, comprehensively, and efficiently.

The Pervasive Challenge of Modern Insomnia

In primary care and integrative settings, insomnia is commonplace and often chronic. Research estimates that between 20% and 50% of patients in primary care environments struggle with persistent insomnia that undermines health, productivity, and well-being (Morin & Benca, 2012). Yet insomnia remains under-recognized and undertreated.

• Under-reporting: Only 25–50% of patients with insomnia raise sleep issues during medical visits.
• Under-assessment: Approximately 75% of patients report that sleep was not discussed at their most recent appointment.

This disconnect is especially alarming in a modern lifestyle loaded with late-night screen exposure and high stress, both of which disrupt circadian rhythms and suppress melatonin. As clinicians, we must treat sleep as a vital sign—routinely screened, measured, and supported (Grandner, 2020).

How Much Sleep We Need Across the Lifespan

Sleep needs are age-dependent and biologically grounded (Hirshkowitz et al., 2015).

• School-Aged Children (6–13 years): 9–11 hours
• Teenagers (14–17 years): 8–10 hours
• Adults (18–64 years): 7–9 hours
• Older adults (65+ years): 7–8 hours

Consistently sleeping below these ranges is associated with short-term impairment and long-term health risks, including cardiovascular disease, diabetes, depression, and neurodegeneration.

Who Is at Risk for Insomnia

Insomnia emerges from a unique blend of biological, psychological, social, and environmental factors. Recognizing risk factors helps prevent, assess, and tailor treatment.

• Advancing age: Changes in sleep architecture and increased medical comorbidities
• Female gender: Hormonal transitions (peri- and postmenopause) increase susceptibility
• Military service: Irregular schedules, deployment stress, and PTSD risk
• Lower socioeconomic status and homelessness: Chronic stress, food insecurity, unstable environments
• Poor health and comorbidities: Chronic pain, cardiovascular, respiratory, and metabolic conditions
• Mental illness: Anxiety, depression, ADHD, bipolar disorder—bidirectional relationships with sleep
• Traumatic brain injury (TBI): Disruption of sleep-regulating neural networks
• Alcohol use disorder: Initial sedation with long-term REM suppression, fragmentation, and neurotoxicity

In my practice, these patterns frequently present, and they respond best to integrated approaches that address both medical and functional contributors.

Sleep Physiology: The Brain’s Master Clock and Sleep-Wake Dynamics

Understanding sleep’s neurophysiology makes insomnia treatment rational and effective. Two core processes govern our sleep-wake cycle: circadian rhythm and sleep-wake homeostasis (Saper, Scammell, & Lu, 2005).

Circadian Rhythm: The Master Timekeeper

• The suprachiasmatic nucleus (SCN) in the hypothalamus acts as the master clock, synchronizing bodily systems to the 24-hour light-dark cycle.
• Light input through retinal pathways informs the SCN, influencing alertness systems by day and melatonin release at night.
• Evening exposure to blue light (screens, LEDs) suppresses melatonin and delays sleep timing—one of the top modern saboteurs of healthy sleep.

Sleep-Wake Homeostasis: The Pressure to Sleep

• The longer we are awake, the stronger the drive to sleep.
• Adenosine accumulates in the brain during wakefulness, inhibiting arousal circuits and stimulating sleep-promoting neurons (VLPO).
• Caffeine blocks adenosine receptors, preventing the sleepiness signal. Mis-timed caffeine can destabilize sleep-wake homeostasis for hours (Porkka-Heiskanen & Kalinchuk, 2011).

Melatonin: The “Hormone of Darkness”

• Melatonin signals nighttime and reduces alertness, body temperature, and readiness for wakefulness.
• Correctly timed melatonin can help align circadian rhythms, particularly for delayed sleep phase, shift work, and jet lag.

Brain Energy and Sleep: Glycogen, Glymphatic Clearance, and Neuroplasticity

Sleep is an active state that restores brain energy, clears metabolic waste, and supports learning and memory.

Glycogen Restoration

• Astrocyte glycogen stores deplete during wakefulness and replenish during deep sleep.
• Adequate slow-wave sleep ensures neurons have energy reserves for optimal function the next day.

The Glymphatic System: Nightly Brain Cleanup

• During deep sleep, the brain’s glymphatic system flushes metabolic byproducts via CSF flowing through perivascular pathways (Xie et al., 2013).
• Key proteins cleared include beta-amyloid (Alzheimer’s), tau (neurofibrillary tangles), and alpha-synuclein (Parkinson’s, Lewy body dementia).
• Chronic insufficient deep sleep can lead to toxic protein accumulation over years—linking insomnia to neurodegeneration risk.

Neuroplasticity and Synaptogenesis

• Sleep supports synaptic homeostasis: strengthening important connections formed during the day and pruning unnecessary ones.
• REM and deep NREM stages facilitate memory consolidation, learning, and emotional processing—critical for cognitive resilience.

Sleep Architecture: The Four Stages and Why They Matter

Sleep cycles through non-REM (NREM) Stages 1–3 and REM multiple times nightly, typically every ~90 minutes. Each stage plays a distinct role.

• NREM Stage 1 (1–10 minutes): Light, easily interrupted sleep; transition from wakefulness
• NREM Stage 2 (30–60 minutes): Parasympathetic shift, core temperature drops, sleep spindles and K-complexes support stability and memory processes
• NREM Stage 3 (20–40 minutes): Slow-wave sleep (delta activity), deep physical restoration, growth hormone release, immune activity, pain modulation
• REM (10–60 minutes): Active brain with muscle atonia, dreaming, procedural and emotional memory consolidation

From an integrative chiropractic and functional perspective, Stage 3 is indispensable for tissue repair, inflammatory modulation, and pain recovery—essential in personal injury care and chronic musculoskeletal conditions.

The Brain’s Wakefulness Systems: Histamine and Orexin

Two neurotransmitter systems heavily influence arousal and sleep stability:

• Histamine: Tuberomammillary nucleus neurons promote wakefulness. Older antihistamines that cross the blood-brain barrier (e.g., diphenhydramine) induce drowsiness by blocking histamine, but are not ideal long-term sleep solutions due to anticholinergic risks.
• Orexin (Hypocretin): Lateral hypothalamic neurons stabilize wakefulness. Loss of orexin neurons causes narcolepsy. Modern DORAs (dual orexin receptor antagonists) gently reduce wake signaling to promote sleep without GABAergic sedation (Neubauer, 2022).

Blue Light: A Modern Circadian Disruptor

Evening exposure to blue wavelengths from phones, tablets, TVs, and LEDs confuses the SCN’s time signals:

• Suppression of melatonin release
• Activation of arousal circuits
• Delayed sleep onset and fragmented sleep

A “digital sunset” 1–2 hours before bed is one of the most potent behavioral levers to recover healthy sleep timing.

Why Untreated Insomnia Is a Serious Health Condition

Insomnia is not simply “being tired.” It disrupts multiple systems:

• Cognitive deficits: attention, memory, executive function, processing speed
• Mood dysregulation: anxiety, depression, irritability; increased suicide risk (Riemann, Krone, Wulff, & Nissen, 2020)
• Injury risk: impaired motor coordination, reaction time; increased work errors and motor vehicle accidents
• Immune dysregulation: elevated inflammatory cytokines (IL-6, CRP), reduced NK cells, lower vaccine antibody titers (Besedovsky, Lange, & Born, 2012; Irwin, 2015)
• Metabolic instability: insulin resistance, dyslipidemia, appetite hormone shifts (ghrelin up, leptin down), weight gain and diabetes risk
• Cardiovascular and cerebrovascular strain: hypertension, atherosclerosis, stroke
• Neurodegeneration risk: inadequate glymphatic clearance, increased Alzheimer’s disease risk and all-cause mortality in older adults

Given these risks, routine sleep assessment is an essential part of modern healthcare (Grandner, 2020).

Making Sleep a Vital Sign in Clinical Practice

I integrate sleep assessment into initial encounters using validated tools:

• Insomnia Severity Index (ISI): Seven-item measure of onset/maintenance difficulties, early awakenings, distress, and impairment
• SATED: Satisfaction, Alertness, Timing, Efficiency, Duration—simple screening domains

A positive screen calls for deeper evaluation using a structured approach and sleep diaries (preferred over consumer wearables, which often lack clinical accuracy and can increase anxiety).

Comprehensive Sleep Evaluation: A Narrative, Patient-Centered Approach

I use OLD CARTS (adapted for sleep) to structure the evaluation:

• Onset: When did insomnia begin? Triggers (stress, meds, illness)?
• Location: Sleep environment (noise, light, comfort)
• Duration: Acute vs. chronic (>3 months)
• Characteristics: Onset vs. maintenance vs. early awakenings
• Aggravating/Alleviating factors: Blue light, caffeine, stress, alcohol; relaxation routines
• Radiation: Impact on functioning (work, family, safety)
• Timing: Nightly patterns, variability
• Severity: Distress and impairment, quantified

I also review health conditions and medications that fragment sleep: pain syndromes, asthma/COPD, GERD, RLS, Parkinson’s, dementia, anxiety, depression, PTSD, thyroid disease, diabetes (nocturia/hypoglycemia), menopause (hot flashes), heart failure (orthopnea), antidepressants/stimulants/steroids/beta-blockers/decongestants.

Balancing Body and Metabolism- Video

When to Refer to Sleep Medicine

Two common scenarios benefit from specialist evaluation:

• Suspected Sleep Apnea: Loud snoring, choking/gasping events, witnessed apneas, nonrefreshing sleep, morning headaches, dry mouth, nocturia, daytime sleepiness—especially in patients with obesity or large neck circumference. Polysomnography is indicated.
• Treatment-Resistant Insomnia: Failure of multiple evidence-based therapies warrants advanced diagnostics and co-management.

Integrative Chiropractic Care in Insomnia Treatment

Chiropractic care fits into insomnia management through structural and neurological mechanisms:

• Pain modulation: Chronic pain is a top disruptor of sleep. Targeted adjustments, soft tissue work, and rehabilitation reduce nociceptive input and allow deeper Stage 3 sleep.
• Autonomic regulation: Spinal and rib mechanics influence respiratory patterns and vagal tone. Adjustments can help shift sympathetic “fight-or-flight” dominance toward parasympathetic “rest-and-digest,” supporting sleep onset and maintenance.
• Movement optimization: Functional rehabilitation refines postural dynamics and breath mechanics, reducing nocturnal discomfort and arousals.

Clinical observations from my practice (as reflected across my publications and case experiences on Sciatica Clinic and LinkedIn) show that integrating chiropractic and functional medicine with CBT-I and medical oversight creates durable improvements in pain and sleep quality:

• Improved sleep continuity after thoracic mobility and diaphragmatic breathing retraining
• Reduced nocturnal arousals in patients with cervical and TMJ-related discomfort following specific adjustments and stabilization exercises
• Enhanced tolerance for sleep restriction therapy when musculoskeletal pain is concurrently addressed

Reference clinical insights:

• Sciatica Clinic: https://sciatica.clinic/
• Professional profile and clinical updates: https://www.linkedin.com/in/dralexjimenez/

Behavioral Foundations: Relaxation, Stimulus Control, and Sleep Restriction

Behavioral therapies form the backbone of modern insomnia care. They not only reduce symptoms but also rewire sleep-related conditioning.

Relaxation Techniques: Calming Hyperarousal

Insomnia often involves an overactive sympathetic system. My go-to methods:

• Mindfulness meditation: Observing thoughts without judgment reduces rumination and sleep anxiety.
• Guided imagery: Creating a multisensory calming scene distracts from worry, lowering physiological arousal.
• Progressive muscle relaxation (PMR): Tension-release cycles heighten awareness of relaxation, easing somatic hyperarousal.
• Diaphragmatic breathing: Slow, low, nasal breathing activates the vagus nerve, stabilizing heart rate and reducing cortisol.

These practices dovetail with chiropractic strategies in autonomic regulation and with rehabilitation exercises that encourage breath and posture balance. Digital tools like CBTI Coach, Headspace, and Calm can help patients practice consistently.

Stimulus Control: Reconditioning the Bed-Sleep Association

Five rules to re-link the bed with sleep:

1. Only go to bed when genuinely sleepy.
2. Use the bed only for sleep and sex—no TV, phones, reading, or worrying.
3. If not asleep within 15–20 minutes, get out of bed. Do something quiet in dim light until sleepy returns; repeat as needed.
4. Maintain a consistent wake time every day.
5. Avoid napping.

This method breaks the cycle of frustrated wakefulness and anxiety in bed.

Sleep Restriction: Consolidating Sleep

Sleep efficiency is the percentage of time in bed spent asleep. In insomnia, it is often low due to prolonged wakefulness in bed. Sleep restriction improves efficiency by limiting time in bed to approximate actual sleep time, then gradually expanding it:

• Determine average sleep time from diaries (e.g., 6 hours).
• Restrict time in bed to 6 hours with a fixed wake time.
• As efficiency rises (>85–90%), increase time in bed by 15–20 minutes.
• Repeat until rested without sacrificing efficiency.

Evidence shows sleep restriction is one of the most powerful methods in CBT-I, but it requires coaching and accountability (Edinger et al., 2021).

Sleep Hygiene: Everyday Rules That Matter

Sleep hygiene supports circadian alignment and reduces sleep pressure conflicts.

• Bedroom environment: Cool, dark, quiet; blackout curtains, white noise, and comfortable bedding
• Minimize napping: If necessary, keep under 30–60 minutes and not late-afternoon
• Caffeine: Avoid after ~2 PM; individualize based on sensitivity
• Alcohol: Avoid near bedtime; it fragments sleep and suppresses REM, causing unrefreshing nights
• Nicotine: Stimulant; avoid near bedtime and overnight
• Consistent schedule: Regular sleep and wake times, even on weekends
• Exercise timing: Morning or afternoon for vigorous activity; gentle stretching/yoga in the evening
• Wind-down ritual: Warm bath, physical book, journaling, prayer/meditation
• Reduce screen time: Digital sunset 1–2 hours before bed
• Clock control: Avoid clock-watching; cover or remove bedside clocks

These habits become particularly effective when combined with stimulus control and sleep restriction.

CBT-I: The Gold Standard of Insomnia Treatment

Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line, evidence-based treatment that provides durable outcomes and minimal side effects (Edinger et al., 2021; Trauer, Qian, Doyle, Rajaratnam, & Cunnington, 2015).

• Cognitive work: Identify and reframe distortions (catastrophizing, unrealistic expectations, misattribution). Shift from “forcing sleep” to “allowing sleep.”
• Behavioral strategies: Sleep hygiene, relaxation, stimulus control, sleep restriction, and tailored homework reinforce new patterns.
• Durability: Skills persist after therapy ends, reducing relapse risk.
• Accessibility: Digital CBT-I can bridge gaps when access to credentialed therapists is limited.

In integrative practice, CBT-I blends seamlessly with chiropractic care (reducing pain), functional medicine (resolving inflammatory and hormonal drivers), and medical oversight (addressing comorbidities).

Pharmacologic Options: Modern, Mechanism-Driven Choices

Medications are adjuncts, not replacements, for behavioral care. When used, I emphasize the lowest effective dose and safety.

Key Counseling Points

• Use the lowest effective dose as little as needed.
• Risks: Falls, confusion, complex sleep behaviors (sleepwalking, sleep-driving, sleep-eating), tolerance and dependence (class-specific).
• Avoid mixing with alcohol, cannabis, muscle relaxants, opioids.
• Avoid chronic OTC antihistamines (diphenhydramine) due to anticholinergic risks and links to cognitive impairment.

Neurochemical Targets

• GABA: Inhibitory; benzodiazepines and Z-drugs enhance GABA-A signaling (sedative hypnotics).
• Histamine: Wakefulness; low-dose doxepin blocks H1 receptors, aiding sleep maintenance.
• Orexin: Wakeful stabilizer; DORAs block orexin receptors to reduce arousal without GABAergic sedation.
• Melatonin: Circadian signal; melatonin supplement and ramelteon (prescription melatonin receptor agonist) support sleep onset and circadian alignment.

Antidepressants Used for Sleep

• Doxepin (Silenor), 3–6 mg: Potent antihistamine effect at low doses; best for sleep maintenance; low dependency risk; common side effect is next-morning drowsiness.
• Off-label agents used in practice: Trazodone, mirtazapine, amitriptyline (evidence mixed; clinical judgment required).

Benzodiazepines

• Examples: Temazepam, triazolam, lorazepam, estazolam, flurazepam
• Pros: Effective, affordable generics
• Cons: High risks—tolerance, dependence, respiratory depression, falls and confusion—use short-term only and avoid in older adults or cognitive impairment

Z-Drugs (Benzodiazepine Receptor Agonists)

• Examples: Zolpidem (IR and CR), eszopiclone, zaleplon
• Pros: Effective; varied onset/duration profiles; generic options
• Cons: Highest risk of complex sleep behaviors; use with caution and clear counseling

Dual Orexin Receptor Antagonists (DORAs)

• Examples: Suvorexant (Belsomra), lemborexant (Dayvigo), daridorexant (Quviviq)
• Mechanism: Block orexin-1 and -2 receptors to gently reduce wakefulness signaling
• Pros: Lower tolerance/dependence risk; effective for sleep maintenance; safe for longer-term use; promising in cognitive impairment populations
• Cons: Cost and prior authorization; food delays absorption—avoid high-fat meals near dosing (Neubauer, 2022)

Melatonin and Melatonin Agonists

• Melatonin supplement: 1–3 mg, 1–2 hours before bedtime; earlier for delayed sleep phase; choose high-quality, third-party-tested brands
• Ramelteon (Rozerem): Selective MT1/MT2 agonist; no abuse potential; best for sleep onset and circadian issues
• Pros: Excellent safety, suitable for minors and circadian misalignment
• Cons: Supplements not FDA-regulated; variability in dosing and purity

Complementary Options

• Magnesium, valerian, lavender: Evidence is limited and inconsistent; I approach with caution, prioritize proven therapies, and monitor closely if patients opt to trial these.

Case-Based Integrative Reasoning: Applying Evidence to Real Patients

Case 1: M.C.—Insomnia with a History of Addiction

• Patient: 57-year-old man; depression, anxiety, hypertension, obesity; past alcohol use disorder (sober >15 years); difficulty with sleep onset and maintenance
• Concerns: Avoids controlled substances; melatonin ineffective
• Assessment priorities:

• • Sleep hygiene deep dive
  • Autonomic tone assessment and pain contributors
  • Obstructive sleep apnea risk—consider sleep study
  • Chiropractic evaluation of biomechanical factors affecting sleep (e.g., cervical, thoracic, rib mechanics; TMJ contribution)

• Treatment plan:
  • Behavioral foundations: Stimulus control, sleep restriction, relaxation practices
  • Pharmacologic options aligned with safety:

• • • Low-dose doxepin for maintenance
    • Ramelteon for sleep onset and circadian support
    • Educate about DORAs (low abuse potential compared to GABAergic agents) if needed

• • Integrative chiropractic care: Adjustments, soft tissue work, breathing retraining, rib mobility to improve autonomic balance and reduce pain
  • Functional medicine workup: Nutrients (magnesium, B vitamins), cortisol rhythm, glycemic control, gut health
  • Sleep study referral: Rule out sleep-disordered breathing

This plan honors his preferences, reduces risk, and treats root contributors—pain, autonomic dysregulation, metabolic stress—alongside evidence-based sleep therapies.

Case 2: C.P.—Insomnia in an Older Adult with Mild Cognitive Impairment

• Patient: 70-year-old woman; chronic insomnia; mild cognitive impairment; recurrent depression; eczema; osteoporosis; using zolpidem 5 mg for ten weeks—tolerance and maintenance insomnia
• Risks: Falls (osteoporosis), cognitive worsening, complex sleep behaviors
• Assessment priorities:

• • Address day naps (2–3 hours)
  • Remove TV from bed, reinforce stimulus control
  • Manage eczema flares (dermatology collaboration; functional triggers)
  • Evaluate mood relapse

• Treatment plan:
  • Reconsider medication:

• • • Avoid increasing zolpidem dose—elevated risk
    • Consider zolpidem CR 6.25 mg cautiously or better: switch to DORA (e.g., lemborexant or daridorexant) with safer profile in older adults and cognitive impairment.

• • Behavioral strategies: Strict stimulus control, sleep restriction adapted for safety, minimize or eliminate naps
  • Integrative care: Chiropractic for pain reduction and autonomic regulation; functional medicine for inflammatory skin triggers; coordinated dermatology care
  • Depression management: Ensure mood support doesn’t conflict with sleep restoration strategies

This approach prioritizes safety, avoids exacerbation of cognitive and fall risks, and addresses behavioral and medical contributors to fragmented sleep.

Stepwise Treatment Strategy: Adjust, Switch Mechanisms, Collaborate

When initial plans don’t achieve sufficient improvement:

• Optimize dose cautiously within safe limits
• Switch mechanisms: From histamine-blocking to orexin antagonism or melatonin agonism, based on insomnia subtype (onset, maintenance, or mixed)
• Collaborate and refer: Sleep medicine for primary sleep disorders; psychiatry for complex psychopharmacology; dermatology, endocrinology, or cardiology for comorbid triggers.

Polypharmacy is reserved for advanced, treatment-resistant cases and should combine different mechanisms (e.g., ramelteon for onset + low-dose doxepin for maintenance) under close supervision.

Long-Term Management and Safe Discontinuation

Insomnia care is a longitudinal process:

• Monitor for tolerance, misuse, and side effects
• Reinforce sleep hygiene at every visit; troubleshoot barriers
• Prioritize CBT-I for enduring skills and relapse prevention
• Taper hypnotics gradually to avoid rebound insomnia or withdrawal, unless severe adverse effects necessitate immediate discontinuation.

How Integrative Chiropractic Care Fits within Medical Oversight and Functional Medicine

At Injury Medical Clinic PA, I co-manage insomnia with Dr. Cardenas, ensuring medical conditions are properly diagnosed and treated while integrative strategies address the broader ecosystem of sleep health.

• Chiropractic care:

• • Pain modulation and biomechanical correction to reduce nocturnal arousals
  • Autonomic balance via spinal and rib mechanics, diaphragmatic support, and vagal activation
  • Rehabilitation to improve posture, breathing, and movement patterns that support sleep comfort

• Internal medicine oversight (Dr. Cardenas):

• • Screening and management of medical comorbidities (OSA, thyroid, diabetes, cardiovascular disease)
  • Pharmacologic safety and monitoring
  • Specialist referrals (sleep medicine, dermatology, psychiatry)

• Functional medicine:

• • Identify root causes—hormonal imbalances, micronutrient deficiencies, inflammation, gut dysbiosis
  • Circadian-aligned nutrition and timing strategies
  • Personalized lifestyle plans with measurable outcomes

This synergy addresses insomnia from every angle—structural, neurological, metabolic, and behavioral—resulting in more consistent and durable recovery of restorative sleep.

Clinical Observations from Practice: What I See in Real-World Care

Across hundreds of cases in our clinic:

• Patients with chronic musculoskeletal pain achieve deeper Stage 3 sleep after targeted adjustments, rib mobility work, and breath retraining—consistent with autonomic downregulation and pain relief mechanisms.
• Sleep restriction adherence improves significantly when daytime pain is controlled; patients report fewer nighttime awakenings due to discomfort.
• In delayed sleep phase patterns, precise melatonin timing combined with a digital sunset and morning light exposure produces meaningful circadian re-anchoring within 2–3 weeks.
• DORAs provide reliable maintenance benefits and reduced next-day effects for older adults compared to Z-drugs, aligning with research on balance and cognition safety.
• Addressing eczema and GERD flares reduces nocturnal pruritus and reflux-related arousals, allowing behavioral therapies to take hold.

For additional context and clinical commentary, see practice content and case insights:

• https://sciatica.clinic/
• https://www.linkedin.com/in/dralexjimenez/

Practical Sleep Playbook: Putting It All Together

• Assess sleep as a vital sign using ISI/SATED and diaries
• Identify subtype: onset, maintenance, early awakenings, mixed
• Screen for apnea and medical contributors; refer as needed
• Initiate CBT-I components: stimulus control, sleep restriction, relaxation
• Enforce sleep hygiene and digital sunset; stabilize wake time
• Integrate chiropractic care for pain and autonomic balance; add functional medicine analysis
• Choose pharmacologic options matched to subtype and patient profile:

• • Sleep onset: Ramelteon, zaleplon, zolpidem IR (caution), melatonin timed properly
  • Sleep maintenance: Low-dose doxepin, DORA (e.g., daridorexant, lemborexant)
  • Mixed insomnia: DORA often preferred

• Monitor safety and progress; adjust doses within limits; switch mechanisms if needed
• Collaborate across disciplines; prioritize long-term CBT-I and taper medications

This roadmap reflects modern, evidence-based methods aligned with patient-centered care.

Conclusion: A Comprehensive, Integrative Path to Restorative Sleep

Insomnia affects the brain and body at every level—from synapses and hormones to cognition, mood, and metabolic health. Treating it effectively demands an integrative model that combines the best of behavioral science (CBT-I), neurophysiology-informed pharmacology, chiropractic care for pain and autonomic regulation, functional medicine to resolve root causes, and internal medicine oversight for safety and comorbidity management.

At Injury Medical Clinic PA in El Paso, Texas, I partner with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933; >40 years of experience) to deliver precisely this kind of care. Our multidisciplinary team aligns research-driven methods with real-world clinical experience—so patients not only sleep better, but also heal deeper, think clearer, and live healthier.

Restorative sleep is not a luxury. It is a biological necessity we can help you reclaim.

References

• Besedovsky, L., Lange, T., & Born, J. (2012). Sleep and immune function. Pflügers Archiv – European Journal of Physiology, 463(1), 121–137.
• Edinger, J. D., Arnedt, J. T., Bertisch, S. M., Carney, C. E., Harrington, J. J., Lichstein, K. L., Sateia, M. J., Troxel, W. M., Zhou, E. S., & Kazmi, U. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 17(2), 255–262.
• Grandner, M. A. (2020). Sleep, health, and society. Sleep Medicine Clinics, 15(2), 319–340.
• Hirshkowitz, M., Whiton, K., Albert, S. M., Alessi, C., Bruni, O., DonCarlos, L., Hazen, N., Herman, J., Katz, E. S., Kheirandish-Gozal, L., Neubauer, D. N., O’Donnell, A. E., Ohayon, M., Peever, J., Rawding, R., Sachdeva, R. C., Setters, B., Vitiello, M. V., & Ware, J. C. (2015). National Sleep Foundation’s sleep time duration recommendations: Methodology and results summary. Sleep Health, 1(1), 40–43.
• Irwin, M. R. (2015). Why sleep is important for health: A psychoneuroimmunology perspective. Annual Review of Psychology, 66, 143–172.
• Morin, C. M., & Benca, R. (2012). Chronic insomnia. The Lancet, 379(9821), 1129–1141.
• Neubauer, D. N. (2022). Orexin receptor antagonists for the treatment of insomnia. Psychiatric Clinics of North America, 45(4), 575–587.
• Riemann, D., Krone, L. B., Wulff, K., & Nissen, C. (2020). Sleep, insomnia, and depression. Neuroforum, 26(1), 35–43.
• Saper, C. B., Scammell, T. E., & Lu, J. (2005). Hypothalamic regulation of sleep and circadian rhythms. Nature, 437(7063), 1257–1263.
• Trauer, J. M., Qian, M. Y., Doyle, J. S., Rajaratnam, S. M. W., & Cunnington, D. (2015). Cognitive behavioral therapy for chronic insomnia: A systematic review and meta-analysis. Annals of Internal Medicine, 163(3), 191–204.
• Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., Takano, T., Deane, R., & Nedergaard, M. (2013). Sleep drives metabolite clearance from the adult brain. Science, 342(6156), 373–377.
• Winkelman, J. W. (2015). Insomnia disorder. New England Journal of Medicine, 373(15), 1437–1440.
• Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125–133.
• Morin, C. M., Colecchi, C., Stone, J., Sood, R., & Brink, D. (1999). Behavioral and pharmacological therapies for late-life insomnia: A randomized controlled trial. JAMA, 281(11), 991–999.
• Leach, M. J., & Page, A. T. (2015). Herbal medicine for insomnia: A systematic review and meta-analysis. Sleep Medicine Reviews, 24, 1–12.
• Seol, J., & Kim, S. (2015). The effects of chiropractic spinal manipulation on the autonomic nervous system: A systematic review of the literature. Journal of the Canadian Chiropractic Association, 59(2), 159–169.

SEO Tags: insomnia, chronic insomnia, sleep deprivation, CBT-I, cognitive behavioral therapy for insomnia, sleep hygiene, stimulus control, sleep restriction, dual orexin receptor antagonists, DORA, doxepin, ramelteon, melatonin, glymphatic system, neuroplasticity, circadian rhythm, adenosine, orexin, histamine, REM sleep, deep sleep, sleep architecture, autonomic nervous system, chiropractic care for sleep, integrative chiropractic care, functional medicine for insomnia, personal injury and sleep, El Paso Texas, Dr. Alex Jimenez DC APRN FNP-BC CFMP IFMCP ATN CCST, Dr. Maria Guadalupe Cardenas MD NPI 1164426749 Texas J2933, internal medicine oversight, treatment-resistant insomnia, polypharmacy, sleep as a vital sign, medical director collaborative physician, Mission Plaza Injury Medical Clinic